1-2 of 2
C. Gregory Albers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

Available to Purchase
Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, C. Gregory Albers, Wen-Pin Chen, Joseph C. Carmichael, Jinah Chung, Ellen Richmond, L.M. Rodriguez, Eva Szabo, Leslie G. Ford, Michael N. Pollak, Frank L. Meyskens
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (2): 203–212.
https://doi.org/10.1158/1940-6207.CAPR-18-0262
Published: 05 February 2020
View articletitled, A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index
Open the PDF for A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index in another window
Includes: Supplementary data
Journal Articles

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

Available to Purchase
Frank L. Meyskens, Jr., Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest Hawk, Gary Kelloff, Michael J. Lawson, Jayashri Kidao, John McCracken, C. Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, Eugene W. Gerner
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (1): 32–38.
https://doi.org/10.1158/1940-6207.CAPR-08-0042
Published: 09 June 2008
View articletitled, Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Open the PDF for Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial in another window
Includes: Supplementary data